qPCR
DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration
Working under a two-year cooperative R&D agreement, the firm will explore its platform for cancer and rare disease mutation detection and in situ cancer cell analyses.
The French firm is developing panels for respiratory diseases, gastrointestinal ailments, women's health, urinary tract infections, sexually transmitted diseases, and meningitis.
Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer
The firm hopes its qPCR-based liquid biopsy test could help identify early-stage NSCLC patients eligible for adjuvant or neoadjuvant anti-EGFR TKI treatment.
BforCure Obtains CE Mark for Portable PCR Thermocycler to Detect SARS-CoV-2
The firm said it has placed its first thermocyclers for rapid SARS-CoV-2 testing in France, including some at an undisclosed airport.
The test relies on using quantitative PCR to target genes encoded by prophages — viruses present in Lyme-causing bacteria, which can be easier to detect than the bacteria itself.